September 24, 2007 - Stentys announced that its drug-eluting bifurcated stent for treatment of blocked coronary artery bifurcations was implanted in a patient, marking the first human implantation of the stent.
The implant was completed in reportedly routine interventional time, and the patient was released from the ICU within hours of the implantation of the Stentys bifurcated stent and was discharged from the hospital shortly after the procedure.
The patent-pending innovation of Stentys' bifurcated stent is that the stent-opening for the side branch can be created reportedly anywhere in the stent after it is implanted in the vessel. The Stentys procedure is performed in three steps. The stent is implanted in the main vessel with an approximate positioning, like a standard stent. The cardiologist chooses the optimal location for the side branch opening by inserting a balloon through the stent mesh, which is a cath lab-standard procedure. Finally, the balloon inflation disconnects the mesh and creates the opening. Stentys' self-expanding property reportedly allows the in situ modeling of the stent to fit the patient’s unique arterial anatomy.
For more information: www.stentys.com
October 31, 2023 
